Sunrise Biological Private Limited
Founded in 2009 and headquartered in Uttar Pradesh, India.
2009 | Lucknow, Uttar Pradesh (India) | Active
Sunrise Biological Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.86 M
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 40.60%
- Profit Growth 42.59%
- Ebitda 1333.05%
- Net Worth 2.70%
- Total Assets 1.27%
About Sunrise Biological
Sunrise Biological Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 September 2009 and has a history of 15 years and five months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.86 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Agnihotri, Jaideep Saraf, and Anand Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900UP2009PTC038191
- Company No.
038191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Trading
Who are the key members and board of directors at Sunrise Biological?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Singh  | Director | 08-Sep-2009 | Current |
| Pankaj Agnihotri | Director | 08-Sep-2009 | Current |
| Jaideep Saraf | Director | 08-Sep-2009 | Current |
Financial Performance of Sunrise Biological.
Sunrise Biological Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.6% increase. The company also saw a substantial improvement in profitability, with a 42.59% increase in profit. The company's net worth moved up by a moderate rise of 2.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunrise Biological?
In 2017, Sunrise Biological had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunrise Biological?
Unlock and access historical data on people associated with Sunrise Biological, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunrise Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunrise Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
